The determination of functional plasminogen activator inhibitors (PAI) based on the inhibition of urokinase: PAI normal range and circadian variations in healthy donors; Comparison with other methods

This publication has 21 references indexed in Scilit:

• Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
• Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: A novel principle
  Thrombosis Research, 1988
• Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for ‘second-site’ interactions
  Biochemical Journal, 1988
• Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations
  Journal of the American College of Cardiology, 1987
• Plasminogen activator inhibitors
  Blood, 1987
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
  Metabolism, 1986
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction
  New England Journal of Medicine, 1985
• Plasminogen activator release during venous stasis and exercise as determined by a new specific assay
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1983
• Regulation of plasminogen activator secretion in mouse peritoneal macrophages
  Biochimie, 1979